203
Participants
Start Date
December 10, 2014
Primary Completion Date
August 30, 2018
Study Completion Date
August 8, 2019
Romiplostim
Romiplostim subcutaneous weekly injection
Research Site, Brussels
Research Site, Budapest
Research Site, Brussels
Research Site, Johannesburg
Research Site, Randwick
Research Site, Parktown
Research Site, Leuven
Research Site, Parkville
Research Site, Liège
Research Site, Durban
Research Site, Debrecen
Research Site, Basel
Research Site, South Brisbane
Research Site, Szeged
Research Site, Tygerberg
Research Site, Zurich
Research Site, Ghent
Research Site, Sankt Gallen
Research Site, New York
Research Site, Pittsburgh
Research Site, Madrid
Research Site, Madrid
Research Site, Atlanta
Research Site, Haifa
Research Site, Montpellier
Research Site, Izmir
Research Site, Nashville
Research Site, Columbus
Research Site, Cincinnati
Research Site, Valencia
Research Site, Indianapolis
Research Site, Petach Tikvah
Research Site, Iowa City
Research Site, Tel Litwinsky
Research Site, Vandœuvre-lès-Nancy
Research Site, Chicago
Research Site, Peoria
Research Site, Kansas City
Research Site, Tel Aviv
Research Site, Monterrey
Research Site, Paris
Research Site, Dallas
Research Site, Fort Worth
Research Site, Houston
Research Site, Beersheba
Research Site, Las Vegas
Research Site, Jerusalem
Research Site, Roseville
Research Site, Moscow
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Krasnodar
Research Site, Volgograd
Research Site, Saratov
Research Site, Belém
Research Site, Jaú
Research Site, São Paulo
Research Site, São Paulo
Research Site, Hamilton
Research Site, Toronto
Research Site, Montreal
Research Site, Montreal
Research Site, Olomouc
Research Site, Ostrava-Poruba
Research Site, Prague
Research Site, Nice
Research Site, Bydgoszcz
Research Site, Lodz
Research Site, Olsztyn
Research Site, Zabrze
Research Site, Barcelona
Research Site, Esplugues de Llobregat
Research Site, Adana
Research Site, Antalya
Research Site, Birmingham
Research Site, Edinburgh
Research Site, London
Research Site, Manchester
Lead Sponsor
Amgen
INDUSTRY